A detailed history of Grove Bank & Trust transactions in Zoetis Inc. stock. As of the latest transaction made, Grove Bank & Trust holds 11,763 shares of ZTS stock, worth $2.08 Million. This represents 0.34% of its overall portfolio holdings.

Number of Shares
11,763
Previous 11,702 0.52%
Holding current value
$2.08 Million
Previous $2.03 Million 13.31%
% of portfolio
0.34%
Previous 0.33%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 11, 2024

BUY
$172.58 - $196.48 $10,527 - $11,985
61 Added 0.52%
11,763 $2.3 Million
Q2 2024

Jul 24, 2024

BUY
$145.54 - $178.83 $483,338 - $593,894
3,321 Added 39.63%
11,702 $2.03 Million
Q1 2024

Apr 30, 2024

BUY
$165.67 - $199.94 $66,268 - $79,976
400 Added 5.01%
8,381 $1.42 Million
Q4 2023

Jan 30, 2024

BUY
$151.44 - $200.09 $66,482 - $87,839
439 Added 5.82%
7,981 $1.58 Million
Q3 2023

Oct 30, 2023

BUY
$167.14 - $192.77 $130,870 - $150,938
783 Added 11.58%
7,542 $1.31 Million
Q2 2023

Jul 27, 2023

BUY
$160.94 - $186.23 $56,168 - $64,994
349 Added 5.44%
6,759 $1.16 Million
Q1 2023

May 10, 2023

SELL
$145.48 - $175.02 $1,309 - $1,575
-9 Reduced 0.14%
6,410 $1.07 Million
Q4 2022

Feb 03, 2023

SELL
$131.14 - $157.47 $43,013 - $51,650
-328 Reduced 4.86%
6,419 $941,000
Q3 2022

Oct 28, 2022

BUY
$148.29 - $182.55 $3,262 - $4,016
22 Added 0.33%
6,747 $1 Million
Q2 2022

Jul 29, 2022

SELL
$155.97 - $200.09 $72,682 - $93,241
-466 Reduced 6.48%
6,725 $1.16 Million
Q1 2022

Apr 22, 2022

SELL
$181.39 - $234.03 $31,199 - $40,253
-172 Reduced 2.34%
7,191 $1.36 Million
Q4 2021

Jan 31, 2022

BUY
$193.69 - $247.03 $82,705 - $105,481
427 Added 6.16%
7,363 $1.8 Million
Q3 2021

Oct 28, 2021

BUY
$189.29 - $209.69 $45,240 - $50,115
239 Added 3.57%
6,936 $1.35 Million
Q2 2021

Jul 28, 2021

SELL
$155.9 - $187.99 $12,939 - $15,603
-83 Reduced 1.22%
6,697 $1.25 Million
Q1 2021

Apr 23, 2021

BUY
$144.0 - $169.39 $74,160 - $87,235
515 Added 8.22%
6,780 $1.07 Million
Q4 2020

Feb 03, 2021

BUY
$157.07 - $174.35 $53,089 - $58,930
338 Added 5.7%
6,265 $1.04 Million
Q3 2020

Oct 30, 2020

BUY
$137.1 - $165.37 $86,784 - $104,679
633 Added 11.96%
5,927 $980,000
Q2 2020

Jul 31, 2020

BUY
$111.92 - $142.53 $174,259 - $221,919
1,557 Added 41.66%
5,294 $725,000
Q1 2020

May 05, 2020

BUY
$92.66 - $144.94 $137,507 - $215,090
1,484 Added 65.87%
3,737 $440,000
Q4 2019

Feb 11, 2020

BUY
$116.25 - $133.25 $16,158 - $18,521
139 Added 6.58%
2,253 $298,000
Q3 2019

Oct 30, 2019

BUY
$112.57 - $128.43 $237,972 - $271,501
2,114 New
2,114 $263,000
Q1 2018

May 07, 2018

SELL
$71.51 - $84.69 $16,089 - $19,055
-225 Closed
0 $0
Q4 2017

Feb 02, 2018

BUY
$63.24 - $72.8 $1,897 - $2,184
30 Added 15.38%
225 $16,000
Q3 2017

Nov 13, 2017

BUY
$59.73 - $65.4 $11,647 - $12,753
195
195 $12,000

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $82.8B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Grove Bank & Trust Portfolio

Follow Grove Bank & Trust and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Grove Bank & Trust, based on Form 13F filings with the SEC.

News

Stay updated on Grove Bank & Trust with notifications on news.